Dr. Agarwal's Health Care Limited has informed the Exchange regarding 'Update on Acquisition'.

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹485.20

prior close

₹490.90

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.8%+3.7% vs market

Hospital peers, median of 18sector-0.6%+3.5% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 3.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-2.8

15m

-2.5

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-0.8+3.7-0.6+3.5

Next day

+4.5-1.2+5.7+0.0+4.5

+5.1+0.2+5.0+0.5+4.6

+2.5+1.5+1.0+1.2+1.3

+0.8+1.2-0.4+2.5-1.8

+5.0+0.9+4.0+2.5+2.5

+4.3+0.9+3.4+2.5+1.8

15d

+11.3+2.9+8.4+5.8+5.5

+5.3+3.2+2.0+4.5+0.7

+9.6-0.4+10.0-2.2+11.7

+4.3-4.0+8.3-2.2+6.4

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 18Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Agarwal's Health Care Limited has acquired an additional 1,32,827 equity shares of Dr. Agarwal's Eye Hospital Limited (AEHL) at INR 5,270 per share (face value INR 10). This follows necessary approvals received by AEHL. With this purchase, the company's shareholding in AEHL has risen to 72.67%, up from its previous level. This is a continuation of an earlier communication dated August 27, 2025. The deal strengthens the parent company's controlling stake in its eye hospital subsidiary.

Likely market impact

The increased stake consolidates Dr. Agarwal's Health Care's control over its core eye hospital business (AEHL), which may be positive for operational integration but involves a significant capital outlay at a premium to face value. No immediate impact on minority shareholders of the listed entity is indicated, though it signals management's confidence in the subsidiary's growth.